Raminhas Carapinha, Maria JoãoFerreira, T. C.Rézio, M. T.Salgado, L.Vaz, S.Costa, G.Ferreira, R.Isidoro, J.Nunes, CarlaTavares, A.2019-11-262019-11-262019-10Carapinha MJ, Ferreira TC, Rézio MT, Salgado L, Vaz S, Costa G, et al. Personal dose equivalent HP(10) in patient’s family members after 131I therapy in thyroid cancer and benign thyroid diseases. In: EANM’19 – Annual Congress of the European Association of Nuclear Medicine, Barcelona (Spain), October 12-16, 2019. Eur J Nucl Med Mol Imaging. 2019;46 Suppl 1:S838-9.http://hdl.handle.net/10400.21/10749Aim of the study - The aim is to quantify the personal equivalent dose Hp(10) of the family members (FMs) of patients submitted to iodine-131 therapy (RAIT): thyroid cancer (TC) or benign thyroid diseases (BTD) and compare Hp(10) values of children and adults.engNuclear medicineIodine-131Thyroid cancerBenign thyroid diseaseDosimetryconference object